The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Development and Validation of a Deep Learning Model for Non–Small Cell Lung Cancer Survival
Open accessAbstract
Importance: There is a lack of studies exploring the performance of a deep learning survival neural network in non-small cell lung cancer (NSCLC). Objectives: To compare the performances of DeepSurv, a deep learning survival neural network with a tumor, node, and metastasis staging system in the prediction of survival and test the reliability of individual treatment recommendations provided by the deep learning survival neural network. Design, Setting, and Participants: In this population-based cohort study, a deep learning-based algorithm was developed and validated using consecutive cases of newly diagnosed stages I to IV NSCLC between January 2010 and December 2015 in a Surveillance, Epidemiology, and End Results database. A total of 127 features, including patient characteristics, tumor stage, and treatment strategies, were assessed for analysis. The algorithm was externally validated on an independent test cohort, comprising 1182 patients with stage I to III NSCLC diagnosed between January 2009 and December 2013 in Shanghai Pulmonary Hospital. Analysis began January 2018 and ended June 2019. Main Outcomes and Measures: The deep learning survival neural network model was compared with the tumor, node, and metastasis staging system for lung cancer-specific survival. The C statistic was used to assess the performance of models. A user-friendly interface was provided to facilitate the survival predictions and treatment recommendations of the deep learning survival neural network model. Results: Of 17 322 patients with NSCLC included in the study, 13 361 (77.1%) were white and the median (interquartile range) age was 68 (61-74) years. The majority of tumors were stage I disease (10 273 [59.3%]) and adenocarcinoma (11 985 [69.2%]). The median (interquartile range) follow-up time was 24 (10-43) months. There were 3119 patients who had lung cancer-related death during the follow-up period. The deep learning survival neural network model showed more promising results in the prediction of lung cancer-specific survival than the tumor, node, and metastasis stage on the test data set (C statistic = 0.739 vs 0.706). The population who received the recommended treatments had superior survival rates than those who received treatments not recommended (hazard ratio, 2.99; 95% CI, 2.49-3.59; P < .001), which was verified by propensity score-matched groups. The deep learning survival neural network model visualization was realized by a user-friendly graphic interface. Conclusions and Relevance: The deep learning survival neural network model shows potential benefits in prognostic evaluation and treatment recommendation with respect to lung cancer-specific survival. This novel analytical approach may provide reliable individual survival information and treatment recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Campanella, G., Hanna, M. G., Geneslaw, L., Miraflor, A., Werneck Krauss Silva, V., Busam, K. J., Brogi, E., Reuter, V. E., Klimstra, D. S., & Fuchs, T. J. (2019) · Nature Medicine · doi:10.1038/s41591-019-0508-1 · Cited by 2,799
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Katzman, J. L., Shaham, U., Cloninger, A., Bates, J., Jiang, T., & Kluger, Y. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0482-1 · Cited by 1,995
Artificial intelligence in surgery: promises and perils
Hashimoto, D. A., Rosman, G., Rus, D., & Meireles, O. R. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002693 · Cited by 1,468
Kather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458 · cited 2×
“(%) Training SEER (test 1) CHINA (test 2) Age at diagnosis, median (range), y 68 (28-95) 68 (19-92) 60 (30-87) Sex Female 6657 (51.”
BackgroundThe International Association for the Study of Lung Cancer Lung Cancer Staging Project
Asamura, H., Chansky, K., Crowley, J., Goldstraw, P., Rusch, V. W., Vansteenkiste, J. F., Watanabe, H., Wu, Y.-L., Zielinski, M., Ball, D., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000678 · Cited by 691
Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence
Liang, H., Tsui, B. Y., Ni, H., Valentim, C. C. S., Baxter, S. L., Liu, G., Cai, W., Kermany, D. S., Sun, X., Chen, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0335-9 · Cited by 659
Liang, W., Zhang, L., Jiang, G., Wang, Q., Liu, L., Liu, D., Wang, Z., Zhu, Z., Deng, Q., Xiong, X., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.6661 · Cited by 649
Self-citationDeep generative models of genetic variation capture the effects of mutations
Riesselman, A. J., Ingraham, J. B., & Marks, D. S. (2018) · Nature Methods · doi:10.1038/s41592-018-0138-4 · Cited by 601
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
Hosny, A., Parmar, C., Coroller, T. P., Grossmann, P., Zeleznik, R., Kumar, A., Bussink, J., Gillies, R. J., Mak, R. H., & Aerts, H. J. W. L. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002711 · Cited by 579
Nam, J. G., Park, S., Hwang, E. J., Lee, J. H., Jin, K.-N., Lim, K. Y., Vu, T. H., Sohn, J. H., Hwang, S., Goo, J. M., et al. (2019) · Radiology · doi:10.1148/radiol.2018180237 · Cited by 539
Li, B., Cui, Y., Diehn, M., & Li, R. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1609 · Cited by 514 · cited 1×
“The median (interquartile range) follow-up time was 24 (10-43) months.”
BackgroundGold, J. S., Gönen, M., Gutiérrez, A., Broto, J. M., García-del-Muro, X., Smyrk, T. C., Maki, R. G., Singer, S., Brennan, M. F., Antonescu, C. R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70242-6 · Cited by 507
Steiner, D. F., MacDonald, R., Liu, Y., Truszkowski, P., Hipp, J. D., Gammage, C., Thng, F., Peng, L., & Stumpe, M. C. (2018) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001151 · Cited by 489
Deep Learning in Medicine—Promise, Progress, and Challenges
Wang, F., Casalino, L. P., & Khullar, D. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.7117 · Cited by 483 · cited 1×
“(%) Training SEER (test 1) CHINA (test 2) Age at diagnosis, median (range), y 68 (28-95) 68 (19-92) 60 (30-87) Sex Female 6657 (51.”
Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P., Strauss, D. C., Levy, A., Griffin, A., Hayes, A. J., Stacchiotti, S., Pechoux, C. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00010-3 · Cited by 478
Chansky, K., Sculier, J.-P., Crowley, J. J., Giroux, D., Van Meerbeeck, J., & Goldstraw, P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a7716e · Cited by 456
Hwang, E. J., Park, S., Jin, K.-N., Kim, J. I., Choi, S. Y., Lee, J. H., Goo, J. M., Aum, J., Yim, J.-J., Cohen, J. G., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1095 · Cited by 447
CENSORING ISSUES IN SURVIVAL ANALYSIS
Leung, K.-M., Elashoff, R. M., & Afifi, A. A. (1997) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.18.1.83 · Cited by 363
Kawaguchi, T., Takada, M., Kubo, A., Matsumura, A., Fukai, S., Tamura, A., Saito, R., Maruyama, Y., Kawahara, M., & Ignatius Ou, S.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2dcd9 · Cited by 354
Sculier, J.-P., Chansky, K., Crowley, J. J., Van Meerbeeck, J., & Goldstraw, P. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31816de2b8 · Cited by 337
Deep learning and artificial intelligence in radiology: current applications and future directions
Yasaka, K., & Abe, O. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002707 · Cited by 238
Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests
Topalovic, M., Das, N., Burgel, P.-R., Daenen, M., Derom, E., Haenebalcke, C., Janssen, R., Kerstjens, H. A. M., Liistro, G., Louis, R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01660-2018 · Cited by 238
Corey, K. M., Kashyap, S., Lorenzi, E., Lagoo-Deenadayalan, S. A., Heller, K., Whalen, K., Balu, S., Heflin, M. T., McDonald, S. R., Swaminathan, M., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002701 · Cited by 204 · cited 1×
“The median (interquartile range) follow-up time was 24 (10-43) months.”
BackgroundTanaka, N., Kanatani, S., Tomer, R., Sahlgren, C., Kronqvist, P., Kaczynska, D., Louhivuori, L., Kis, L., Lindh, C., Mitura, P., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0139-0 · Cited by 202
Gertych, A., Swiderska-Chadaj, Z., Ma, Z., Ing, N., Markiewicz, T., Cierniak, S., Salemi, H., Guzman, S., Walts, A. E., & Knudsen, B. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37638-9 · Cited by 188
Survival outcome prediction in cervical cancer: Cox models vs deep-learning model
Matsuo, K., Purushotham, S., Jiang, B., Mandelbaum, R. S., Takiuchi, T., Liu, Y., & Roman, L. D. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.030 · Cited by 179
On Deep Learning for Medical Image Analysis
Carin, L., & Pencina, M. J. (2018) · JAMA · doi:10.1001/jama.2018.13316 · Cited by 167
Xie, D., Marks, R., Zhang, M., Jiang, G., Jatoi, A., Garces, Y. I., Mansfield, A., Molina, J., & Yang, P. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000585 · Cited by 163
Self-citationDeep Neural Networks for Classification of LC-MS Spectral Peaks
Kantz, E. D., Tiwari, S., Watrous, J. D., Cheng, S. C., & Jain, M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02983 · Cited by 125
Shi, S., Hua, J., Liang, C., Meng, Q., Liang, D., Xu, J., Ni, Q., & Yu, X. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002668 · Cited by 102
Shaffie, A., Soliman, A., Fraiwan, L., Ghazal, M. A., Taher, F., Dunlap, N., Wang, B. Z., van Berkel, V. H., Keynton, R. S., Elmaghraby, A. S., et al. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818798800 · Cited by 76
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Smith, C. C., Chai, S., Washington, A. R., Lee, S. J., Landoni, E., Field, K. P., Garness, J. A., Bixby, L. M., Selitsky, S. R., Parker, J. S., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0155 · Cited by 67
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care
Simon, G. R., Dinardo, C. D., Takahashi, K., Cascone, T., Powers, C. A., Stevens, R. J., Allen, J., Antonoff, M. B., Gomez, D. R., Keane, P., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0257 · Cited by 64
Yap, W., Shih, M., Kuo, C., Pai, P., Chou, W., Chang, K., Tsai, M., & Tsang, N. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3242 · Cited by 60
Risk calculators and decision aids are not enough for shared decision making.
Kopecky, K. E., Urbach, D., & Schwarze, M. L. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.2446 · Cited by 56
Ren, J., Karagoz, K., Gatza, M. L., Singer, E. A., Sadimin, E. T., Foran, D. J., & Qi, X. (2018) · Journal of medical imaging · doi:10.1117/1.jmi.5.4.047501 · Cited by 31
On algorithms, machines, and medicine
Coiera, E. W. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30835-0 · Cited by 31
Wang, Y., Qu, X. H., Kam, N., Wang, K., Shen, H., Liu, Q., & Du, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4513-4 · Cited by 18
Cited by
Artificial intelligence for clinical oncology
Kann, B. H., Hosny, A., & Aerts, H. J. W. L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.002 · Cited by 370
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
Zhang, C., Xu, J., Tang, R., Yang, J., Wang, W., Yu, X., & Shi, S. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01514-5 · Cited by 148
Leivaditis, V., Maniatopoulos, A. A., Lausberg, H., Mulita, F., Papatriantafyllou, A., Liolis, E., Beltsios, E., Adamou, A., Kontodimopoulos, N., & Dahm, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082729 · Cited by 76
Matsumoto, T., Walston, S. L., Walston, M., Kabata, D., Miki, Y., Shiba, M., & Ueda, D. (2022) · Journal of Digital Imaging · doi:10.1007/s10278-022-00691-y · Cited by 15
Metadata
- Authors
- She, Y., Jin, Z., Wu, J., Deng, J., Zhang, L., Su, H., Jiang, G., Liu, H., Xie, D., Cao, N., Ren, Y., & Chen, C.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-06-03
- Volume
- 3
- Issue
- 6
- Pages
- e205842
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3031635948
- Cited by
- 267
- References
- 40
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.